Sep 03 — Our Founder and Chief Scientific Officer Professor Charalambos Antoniades today presented a late-breaking paper at the ESC Congress in Paris, with a simultaneous publication in the European Heart Journal. It describes novel ground-breaking AI-powered biomarkers that enhance and add on to our existing FAI technology. It not only looks at inflammation signatures in the fat, but also adverse fibrotic and microvascular remodelling. The result is a marked increase in the power of cardiovascular risk prediction, well above and beyond the current start of the art. Caristo is proud that its proprietary CaRi-HEART algorithms were used in part of the research!
Click here for the European Heart Journal article.